Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues

Home > Science Hub > Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues
Back to the list

November 9, 2020

Maxim Isabelle, Michael Schirm, Gwenaël Pottiez, Rudolf Guilbaud and Lorella Di Donato

Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues, SITC 2020

Capion_Poster_SITC_FFPE

 

Download the poster

You might also be interested by

Posters

Quantification of sBCMA in Human Plasma using a High-Throughput Mass Spectrometry Workflow for Exploratory, CAP/CLIA or Regulated Studies

November 9, 2020

Proteomics/Mass Spectrometry

More info

Posters

Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

July 29, 2020

Proteomics/Mass Spectrometry

More info

Insight from our experts

Insight From Our Experts:
Discussing MHC Peptide Analysis with Eustache Paramithiotis

July 13, 2020

Proteomics/Mass Spectrometry

More info

Scientific Publications

Immunopeptidomic Data Integration to Artificial Neural Networks Enhances
Protein-Drug Immunogenicity Prediction

June 23, 2020

Immune Monitoring

More info